China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Cash Flow-to-Debt Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of CN¥36.82 Million could theoretically repay 0% of its total liabilities (CN¥1.16 Billion) in one year. Explore China Resources Boya Bio pharmaceutical long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for China Resources Boya Bio pharmaceutical Group Co Ltd across 17 annual periods. Also explore China Resources Boya Bio pharmaceutical assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year debt coverage analysis for China Resources Boya Bio pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see China Resources Boya Bio pharmaceutical market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥116.69 Million | CN¥1.16 Billion | ▼ -69.5% |
| 2024 | 0.33x | CN¥299.78 Million | CN¥913.38 Million | ▼ -74.0% |
| 2023 | 1.26x | CN¥641.73 Million | CN¥508.07 Million | ▲ +58.5% |
| 2022 | 0.80x | CN¥596.44 Million | CN¥748.35 Million | ▼ -58.5% |
| 2021 | 1.92x | CN¥1.35 Billion | CN¥701.30 Million | ▲ +157.9% |
| 2020 | 0.74x | CN¥718.58 Million | CN¥966.08 Million | ▲ +923.7% |
| 2019 | -0.09x | CN¥-114.51 Million | CN¥1.27 Billion | ▼ -437.0% |
| 2018 | 0.03x | CN¥34.90 Million | CN¥1.30 Billion | ▲ +233.4% |
| 2017 | -0.02x | CN¥-23.82 Million | CN¥1.19 Billion | ▼ -102.9% |
| 2016 | 0.69x | CN¥198.76 Million | CN¥287.30 Million | ▲ +31.8% |
| 2015 | 0.52x | CN¥147.02 Million | CN¥280.11 Million | ▼ -59.6% |
| 2014 | 1.30x | CN¥121.88 Million | CN¥93.90 Million | ▲ +129.9% |
| 2013 | 0.56x | CN¥89.11 Million | CN¥157.85 Million | ▼ -84.2% |
| 2012 | 3.58x | CN¥92.36 Million | CN¥25.80 Million | ▲ +200.7% |
| 2011 | 1.19x | CN¥81.53 Million | CN¥68.48 Million | ▲ +370.1% |
| 2010 | 0.25x | CN¥24.77 Million | CN¥97.79 Million | ▼ -25.8% |
| 2009 | 0.34x | CN¥51.88 Million | CN¥151.93 Million | — |